Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Impact of autologous dendritic cell-based immunotherapy (AGS-004) on B- and T-cell subset changes and immune activation in HIV-infected patients receiving antiretroviral therapy.

Jenabian MA, Nicolette CA, Tcherepanova IY, Debenedette MA, Gilmore N, Routy JP.

J Acquir Immune Defic Syndr. 2013 Dec 1;64(4):345-50. doi: 10.1097/QAI.0b013e3182a4b9ad.

PMID:
24025338
[PubMed - indexed for MEDLINE]
2.

Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy.

Routy JP, Boulassel MR, Yassine-Diab B, Nicolette C, Healey D, Jain R, Landry C, Yegorov O, Tcherepanova I, Monesmith T, Finke L, Sékaly RP.

Clin Immunol. 2010 Feb;134(2):140-7. doi: 10.1016/j.clim.2009.09.009. Epub 2009 Nov 4.

PMID:
19889582
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.

Benito JM, López M, Lozano S, Ballesteros C, Martinez P, González-Lahoz J, Soriano V.

J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):373-81.

PMID:
15764953
[PubMed - indexed for MEDLINE]
4.

Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.

Gray CM, Schapiro JM, Winters MA, Merigan TC.

AIDS Res Hum Retroviruses. 1998 May 1;14(7):561-9.

PMID:
9591710
[PubMed - indexed for MEDLINE]
5.

Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.

Plana M, García F, Gallart T, Tortajada C, Soriano A, Palou E, Maleno MJ, Barceló JJ, Vidal C, Cruceta A, Miró JM, Gatell JM.

AIDS. 2000 Sep 8;14(13):1921-33.

PMID:
10997396
[PubMed - indexed for MEDLINE]
6.

Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors.

Plana M, Martínez C, García F, Maleno MJ, Barceló JJ, García A, Lejeune M, Vidal C, Cruceta A, Miró JM, Pumarola T, Gallart T, Gatell JM.

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):429-34.

PMID:
11981357
[PubMed - indexed for MEDLINE]
7.

Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-1 infection.

Giorgi JV, Majchrowicz MA, Johnson TD, Hultin P, Matud J, Detels R.

AIDS. 1998 Oct 1;12(14):1833-44.

PMID:
9792384
[PubMed - indexed for MEDLINE]
8.

Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.

Dyrhol-Riise AM, Voltersvik P, Olofsson J, Asjö B.

AIDS. 1999 Dec 3;13(17):2365-76.

PMID:
10597778
[PubMed - indexed for MEDLINE]
9.

Increased proliferation within T lymphocyte subsets of HIV-infected adolescents.

Starr SE, Sarr M, Campbell DE, Wilson CM, Douglas SD.

AIDS Res Hum Retroviruses. 2002 Nov 20;18(17):1301-10.

PMID:
12487818
[PubMed - indexed for MEDLINE]
10.

Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection.

Bisset LR, Cone RW, Fischer M, Battegay M, Vernazza PL, Dubs RW, Weber R, Grob PJ, Opravil M; Swiss HIV Cohort Study.

J Acquir Immune Defic Syndr. 2001 Jul 1;27(3):266-71.

PMID:
11464146
[PubMed - indexed for MEDLINE]
11.

Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.

Bisset LR, Cone RW, Huber W, Battegay M, Vernazza PL, Weber R, Grob PJ, Opravil M.

AIDS. 1998 Nov 12;12(16):2115-23.

PMID:
9833852
[PubMed - indexed for MEDLINE]
12.

Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir.

Levacher M, Bouscarat F, Landman R, Chau F, Damond F, Gaudebout C, Mathez D, Leibowitch J, Saimot AG, Sinet M.

AIDS Res Hum Retroviruses. 2000 Nov 20;16(17):1869-75.

PMID:
11118072
[PubMed - indexed for MEDLINE]
13.

Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART.

Resino S, Navarro J, Bellón JM, Gurbindo D, León JA, Muñoz-Fernández MA.

Clin Exp Immunol. 2001 Aug;125(2):266-73.

PMID:
11529919
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

CD4(+) T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy.

Resino S, Seoane E, Gutiérrez MD, León JA, Muñoz-Fernández MA.

J Acquir Immune Defic Syndr. 2006 Jul;42(3):269-76.

PMID:
16810122
[PubMed - indexed for MEDLINE]
15.

HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.

Steel A, Cox AE, Shamji MH, John L, Nelson M, Henderson DC, Gotch FM, Gazzard BG, Kelleher P.

Antivir Ther. 2007;12(6):971-5.

PMID:
17926652
[PubMed - indexed for MEDLINE]
16.

mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.

Van Gulck E, Vlieghe E, Vekemans M, Van Tendeloo VF, Van De Velde A, Smits E, Anguille S, Cools N, Goossens H, Mertens L, De Haes W, Wong J, Florence E, Vanham G, Berneman ZN.

AIDS. 2012 Feb 20;26(4):F1-12. doi: 10.1097/QAD.0b013e32834f33e8.

PMID:
22156965
[PubMed - indexed for MEDLINE]
17.

Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.

Pettersen FO, Taskén K, Kvale D.

Clin Exp Immunol. 2010 Aug;161(2):315-23. doi: 10.1111/j.1365-2249.2010.04179.x. Epub 2010 May 10.

PMID:
20491784
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.

Lim A, Tan D, Price P, Kamarulzaman A, Tan HY, James I, French MA.

AIDS. 2007 Jul 31;21(12):1525-34.

PMID:
17630546
[PubMed - indexed for MEDLINE]
19.

Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.

Al-Harthi L, Siegel J, Spritzler J, Pottage J, Agnoli M, Landay A.

AIDS. 2000 May 5;14(7):761-70.

PMID:
10839583
[PubMed - indexed for MEDLINE]
20.

Expansion of CD57 and CD62L-CD45RA+ CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infection.

Lieberman J, Trimble LA, Friedman RS, Lisziewicz J, Lori F, Shankar P, Jessen H.

AIDS. 1999 May 28;13(8):891-9.

PMID:
10371169
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk